Jpmorgan Chase & CO Amryt Pharma PLC Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$7.0 - $14.77 $21,497 - $45,358	3,071 Added 153550.0%	3,073 $44,000
Q1 2022 May 11, 2022	SELL	$6.3 - $10.86 $686 - $1,183	-109 Reduced 98.2%	2 $0
Q4 2021 Feb 10, 2022	BUY	$9.44 - $12.24 $424 - $550	45 Added 68.18%	111 $1,000
Q3 2021 Nov 12, 2021	BUY	$9.63 - $12.47 $635 - $823	66 New	66 $1,000

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.